Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort.

"Declarations Ethics approval and consent to participateAll studies were approved by the national ethics committees. Consent for publicationNot applicable. Competing interestsLMG is supported by Pfizer for attending meetings and/or travel. NT is supported by Pfizer for attending meetings and/or travel and non-financial supports from Gilead outside this work. The other authors declare that they have no competing interests. Competing interests LMG is supported by Pfizer for attending meetings and/or travel. NT is supported by Pfizer for attending meetings and/or travel and non-financial supports from Gilead outside this work. The other authors declare that they have no competing interests."

"Funding SB and JLP. are supported by the French National Research Agency in the framework of the ‘Investissements d’avenir’ program (ANR-15-IDEX-02) and Grenoble Alpes University Foundation Chairs of excellence: “e-health and integrated care and trajectories medicine and MIAI artificial intelligence” This work has been partially supported by MIAI @ Grenoble Alpes (ANR-19-P3IA-0003)."